Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer

Sara Moufarrij(George Washington University), Katherine B. Chiappinelli(George Washington University)
Scientific Reports
February 26, 2020
Cited by 112


Related Papers